Next Article in Journal
Testing the Protective Effects of Sulfobutylether-Βeta-Cyclodextrin (SBECD) and Sugammadex against Chlorpromazine-Induced Acute Toxicity in SH-SY5Y Cell Line and in NMRI Mice
Next Article in Special Issue
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis
Previous Article in Journal
Inorganic Nanoflowers—Synthetic Strategies and Physicochemical Properties for Biomedical Applications: A Review
Previous Article in Special Issue
Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(9), 1889; https://doi.org/10.3390/pharmaceutics14091889
Action Date Notes Link
article xml file uploaded 7 September 2022 10:03 CEST Original file -
article xml uploaded. 7 September 2022 10:03 CEST Update https://www.mdpi.com/1999-4923/14/9/1889/xml
article pdf uploaded. 7 September 2022 10:03 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1889/pdf
article html file updated 7 September 2022 10:09 CEST Original file https://www.mdpi.com/1999-4923/14/9/1889/html
Back to TopTop